###begin article-title 0
Identification of an imidazoline binding protein: Creatine kinase and an imidazoline-2 binding site
###end article-title 0
###begin p 1
This document may be redistributed and reused, subject to .
###end p 1
###begin title 2
Abstract
###end title 2
###begin p 3
###xml 125 126 125 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 129 130 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 136 137 136 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 226 227 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 348 349 348 349 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 636 637 624 625 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 881 882 857 858 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 893 894 869 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 966 969 940 943 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#160;1</sup>
###xml 989 990 963 964 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1119 1120 1093 1094 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1248 1249 1221 1222 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1399 1400 1360 1361 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1559 1560 1520 1521 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1615 1616 1576 1577 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 577 583 <span type="species:ncbi:9986">rabbit</span>
###xml 588 591 <span type="species:ncbi:10116">rat</span>
Drugs that bind to imidazoline binding proteins have major physiological actions. To date, three subtypes of such proteins, I1, I2 and I3, have been proposed, although characterisations of these binding proteins are lacking. I2 binding sites are found throughout the brain, particularly dense in the arcuate nucleus of the hypothalamus. Selective I2 ligands demonstrate antidepressant-like activity and the identity of the proteins that respond to such ligands remained unknown until now. Here we report the isolation of a approximately 45 kDa imidazoline binding protein from rabbit and rat brain using a high affinity ligand for the I2 subtype, 2-BFI, to generate an affinity column. Following protein sequencing of the isolated approximately 45 kDa imidazoline binding protein, we identified it to be brain creatine kinase (B-CK). B-CK shows high binding capacity to selective I2 ligands; [3H]-2-BFI (5 nM) specifically bound to B-CK (2330 +/- 815 fmol mg protein- 1). We predicted an I2 binding pocket near the active site of B-CK using molecular modelling. Furthermore, B-CK activity was inhibited by a selective I2 irreversible ligand, where 20 muM BU99006 reduced the enzyme activity by 16%, confirming the interaction between B-CK and the I2 ligand. In summary, we have identified B-CK to be the approximately 45 kDa imidazoline binding protein and we have demonstrated the existence of an I2 binding site within this enzyme. The importance of B-CK in regulating neuronal activity and neurotransmitter release may well explain the various actions of I2 ligands in brain and the alterations in densities of I2 binding sites in psychiatric disorders.
###end p 3
###begin title 4
Abbreviations
###end title 4
###begin title 5
Keywords
###end title 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 244 245 244 245 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 324 345 324 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3" ref-type="bibr">Bousquet et al., 1984</xref>
###xml 353 354 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 494 514 494 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr">Alemany et al., 1997</xref>
###xml 522 523 522 523 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 605 622 602 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5" ref-type="bibr">Chan et al., 1994</xref>
###xml 748 763 745 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib27" ref-type="bibr">Li et al., 1994</xref>
###xml 778 797 775 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib21" ref-type="bibr">Hudson et al., 2001</xref>
###xml 960 978 957 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib42" ref-type="bibr">Smith et al., 2009</xref>
The existence of imidazoline binding sites has been established and their functions together with underlying mechanisms have been debated for several years. Currently, there are three defined subtypes for these sites. The clonidine preferring I1 site is found in the brainstem and is associated with blood pressure control (Bousquet et al., 1984). The I2 sites have been identified using idazoxan and these are predominantly found in the brain and liver where they regulate monoamine turnover (Alemany et al., 1997). The I3 sites are located in pancreatic beta-cells and these regulate insulin secretion (Chan et al., 1994). The physiological relevance of these sites is strengthened by the findings that endogenous substances especially agmatine (Li et al., 1994) and harmane (Hudson et al., 2001) have significant activity at one or more of these sites. Furthermore, ligands targeting these sites demonstrate therapeutic potentials in psychiatric disorders (Smith et al., 2009).
###end p 7
###begin p 8
###xml 52 53 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 295 301 295 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 356 357 356 357 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 401 402 401 402 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 464 482 464 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib29" ref-type="bibr">Lione et al., 1998</xref>
###xml 453 456 <span type="species:ncbi:10116">rat</span>
In order to advance our knowledge of properties of I2 binding proteins, several selective ligands were synthesised including 2-(2-benzofuranyl)2-imidazoline (2-BFI), 2-(4,5-dihydroimidaz-2-yl)quinoline (BU224) and an irreversible ligand 5-isothiocyanoato-2-benzofuranyl-2-imidazoline (BU99006) (Fig. 1). These ligands have established the distribution of I2 sites; most interestingly, the density of I2 sites is extremely high in the arcuate nucleus in rat brain (Lione et al., 1998).
###end p 8
###begin p 9
###xml 29 30 29 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 98 99 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 288 305 288 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr">Finn et al., 2003</xref>
###xml 373 374 373 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 453 486 453 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16 bib17" ref-type="bibr">Garc&#237;a-Sevilla et al., 1996, 1998</xref>
###xml 598 619 598 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib38" ref-type="bibr">Reynolds et al., 1996</xref>
###xml 639 640 639 640 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 710 750 710 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20 bib39" ref-type="bibr">Hudson et al., 1996; Sastre et al., 1996</xref>
###xml 777 778 777 778 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 808 825 808 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib34" ref-type="bibr">Nutt et al., 1995</xref>
###xml 966 967 966 967 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 975 993 975 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib29" ref-type="bibr">Lione et al., 1998</xref>
###xml 562 570 <span type="species:ncbi:9606">patients</span>
###xml 695 698 <span type="species:ncbi:10116">rat</span>
###xml 703 708 <span type="species:ncbi:9606">human</span>
Understanding the nature of I2 sites is important for a number of reasons. Ligands selective for I2 sites have been shown to regulate the release of biogenic amines such as dopamine and noradrenaline and probably through these mechanisms, they demonstrate antidepressant-like properties (Finn et al., 2003). Furthermore, post-mortem studies have shown that the density of I2 sites was altered in suicide/depression and increased in Alzheimer's disease (Garcia-Sevilla et al., 1996, 1998), whereas there was a profound loss of these sites in the basal ganglia of patients with Huntington's disease (Reynolds et al., 1996). Moreover, brain I2 sites are down-regulated in opiate dependence both in rat and human (Hudson et al., 1996; Sastre et al., 1996). In addition, selective I2 ligands promote food intake (Nutt et al., 1995), which is presumed to be an effect through the arcuate nucleus of the hypothalamus since this brain region has a markedly high density of I2 sites (Lione et al., 1998).
###end p 9
###begin p 10
###xml 216 217 216 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 323 346 323 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib32" ref-type="bibr">Molderings et al., 2007</xref>
###xml 358 359 358 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 392 393 392 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 469 470 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 629 630 629 630 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 640 659 640 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib37" ref-type="bibr">Parini et al., 1996</xref>
###xml 713 752 713 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib36 bib23" ref-type="bibr">Ozaita et al., 1997; Jones et al., 2007</xref>
###xml 785 786 785 786 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 847 865 847 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr">Eglen et al., 1998</xref>
###xml 960 961 960 961 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 971 990 971 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib36" ref-type="bibr">Ozaita et al., 1997</xref>
###xml 1050 1051 1050 1051 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1091 1092 1091 1092 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1221 1241 1221 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">Escrib&#225; et al., 1999</xref>
###xml 1267 1268 1267 1268 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1397 1417 1385 1405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr">Escrib&#225; et al., 1995</xref>
###xml 1529 1562 1517 1550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16 bib17" ref-type="bibr">Garc&#237;a-Sevilla et al., 1996, 1998</xref>
###xml 1386 1389 <span type="species:ncbi:10116">rat</span>
The identity of imidazoline binding proteins has attracted interests of many research groups; however, determining its identity has proven challenging. It is only recently that an imidazoline binding protein of the I1-subtype was proposed to be a receptor that belongs to the sphingosine-1-phosphate (S1P)-receptor family (Molderings et al., 2007). For the I2-subtype, the high abundance of I2 sites in liver led to an exploration of monoamine oxidase as the possible I2 binding protein over a decade ago. Subsequently, it was reported that both monoamine oxidase (MAO) isoenzymes (A and B) show a low affinity binding site for I2 ligands (Parini et al., 1996) and that the nature of interaction was competitive (Ozaita et al., 1997; Jones et al., 2007). However, the distribution of I2 site is not contiguous with the distribution of MAO A or B (Eglen et al., 1998) and discrepancies in the pharmacological profiles regarding the interaction between MAO and I2 ligands (Ozaita et al., 1997) indicated that there must be other proteins that contain I2 binding domains. To date, a number of I2 binding proteins have successfully been isolated and their existence as a heterogeneous population has strongly been suggested (Escriba et al., 1999). However, a definitive I2 binding protein has yet to be identified; although, a approximately 45 kDa protein has previously been isolated from rat brain (Escriba et al., 1995) and other studies have shown the expression of this protein is altered in Alzheimer's disease and depression (Garcia-Sevilla et al., 1996, 1998).
###end p 10
###begin p 11
###xml 165 166 153 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 375 376 363 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 83 89 <span type="species:ncbi:9986">rabbit</span>
###xml 94 97 <span type="species:ncbi:10116">rat</span>
The aim of this study was to isolate the approximately 45 kDa binding protein from rabbit and rat brain, and determine its identity. We utilised a highly selective I2 ligand, 2-BFI, as a key tool in affinity chromatography and employed N-terminal protein sequencing to reveal the identity of the isolated protein. Subsequently, we confirmed properties of this protein as an I2 binding protein using biochemical and pharmacological techniques.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 14 15 14 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Isolation of I2 binding proteins using 2-BFI affinity column
###end title 13
###begin p 14
###xml 21 22 21 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 399 405 387 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 574 580 550 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 951 966 915 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib46" ref-type="bibr">Wu et al., 2002</xref>
###xml 0 6 <span type="species:ncbi:9986">Rabbit</span>
###xml 10 13 <span type="species:ncbi:10116">rat</span>
###xml 1020 1026 <span type="species:ncbi:9986">rabbit</span>
###xml 1057 1063 <span type="species:ncbi:9986">rabbit</span>
###xml 1292 1295 <span type="species:ncbi:10116">rat</span>
###xml 1418 1421 <span type="species:ncbi:10116">rat</span>
Rabbit or rat brain I2 binding proteins were solubilised, loaded onto the 2-BFI affinity column and then eluted off using idazoxan (20 mM). The isolated proteins were concentrated and subjected to SDS-PAGE analysis for further separation according to their molecular weight. Coomassie Blue staining revealed a strong band at approximately 45 kDa together with several weaker bands of various sizes (Fig. 2). This approximately 45 kDa band was absent from the control column, in which 2-BFI was not linked to the matrix, indicating specific binding of this protein to 2-BFI (Fig. 2). The proteins separated by SDS-PAGE analysis were transferred onto PVDF membranes. The approximately 45 kDa band was excised and subjected to N-terminal sequencing. The resulting peptide contained a ten amino acid sequence of -PFSNTHNTLK-. This sequence was used to search for the identity of this protein in a protein sequence database (Protein Information Resources, Wu et al., 2002). The exact match for the ten amino acid sequence of rabbit brain origin was confirmed as rabbit brain creatine kinase (B-CK, 43 kDa, EC 2.7.3.2); the match was found at the N-terminus of this enzyme. Extensive search of the identified peptide in protein sequence databases revealed no other possible candidate proteins. For rat brain, a BLAST search programme revealed the most probable protein for this isolated protein (approximately 45 kDa) to be rat brain creatine kinase.
###end p 14
###begin title 15
###xml 1 2 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
[3H]-2-BFI binding to B-CK
###end title 15
###begin p 16
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 118 119 118 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 255 256 255 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 294 297 292 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#160;1</sup>
###xml 299 300 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 374 375 372 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 400 406 397 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 468 469 465 466 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 494 495 491 492 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 531 532 528 529 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 609 610 606 607 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 658 659 655 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 725 726 721 722 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 779 780 775 776 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 802 803 798 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 810 811 806 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 823 824 819 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 864 865 860 861 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 885 886 881 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 954 955 950 951 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1012 1013 1008 1009 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 149 155 <span type="species:ncbi:9986">rabbit</span>
###xml 165 171 <span type="species:ncbi:9986">rabbit</span>
###xml 209 215 <span type="species:ncbi:9986">Rabbit</span>
###xml 589 595 <span type="species:ncbi:9986">rabbit</span>
###xml 743 749 <span type="species:ncbi:9986">rabbit</span>
###xml 759 765 <span type="species:ncbi:9986">rabbit</span>
Radioligand binding centrifugation assay was performed using [3H]-2-BFI (5 nM) in order to determine and compare the I2 binding capacity of purified rabbit B-CK and rabbit whole brain P2 membrane preparation. Rabbit B-CK was able to specifically bind to [3H]-2-BFI (2330 +/- 815 fmol mg protein- 1, n = 7), where the specific binding was determined using another selective I2 ligand, BU224 (10 muM) (Fig. 3). These data indicate specific binding of the two selective I2 ligands to an apparent I2 site on this enzyme. The specific I2 binding was approximately 4 fold higher in B-CK than in rabbit whole brain P2 membrane. Pre-treatment with the irreversible I2 ligand, BU99006 (10 muM), significantly attenuated the specific I2 binding in both rabbit B-CK and rabbit whole brain P2 membranes (Student's t-test, P < 0.04 and P < 0.03 respectively), indicating that I2 sites occupied by [3H]-2-BFI were displaced by BU99006 due to its affinity also at the I2 sites. These data strongly support the existence of an I2 binding site on B-CK.
###end p 16
###begin title 17
###xml 12 13 12 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Effects of I2 ligands on B-CK activity
###end title 17
###begin p 18
###xml 65 66 65 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 318 319 317 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 463 466 462 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 638 644 636 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 740 759 738 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib43" ref-type="bibr">Tyacke et al., 2002</xref>
The activity of B-CK was measured in the presence or absence of I2 ligands (1-20 muM; pre-incubation) using phosphocreatine (0-35 mM) as the substrate. There were no apparent changes in B-CK activity in the presence of 2-BFI, BU224, harmane, agmatine or amiloride, all of which have been reported to have affinity at I2 sites (data not shown). However, BU99006 inhibited the B-CK activity in a concentration-dependent manner, with the reductions in the apparent Vmax by 8%, 10% and 16% at 5, 10 and 20 muM, respectively. These data indicate that the inhibition of B-CK activity by BU99006 at the tested concentrations is non-competitive (Fig. 4), which is consistent with the pharmacological profile of this compound determined previously (Tyacke et al., 2002).
###end p 18
###begin title 19
###xml 24 25 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Molecular modelling of I2 ligands docking to B-CK crystal structure
###end title 19
###begin p 20
###xml 283 284 271 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 66 73 <span type="species:ncbi:9031">chicken</span>
###xml 110 117 <span type="species:ncbi:9031">Chicken</span>
###xml 168 171 <span type="species:ncbi:10116">rat</span>
###xml 176 182 <span type="species:ncbi:9986">rabbit</span>
###xml 442 449 <span type="species:ncbi:9031">chicken</span>
Currently, the only B-CK crystal structure available is that from chicken (Protein Data Bank ID (PDB): 1QH4). Chicken B-CK demonstrates approximately 90% homology with rat and rabbit brain B-CKs, and thus this was considered suitable for use in our molecular modelling studies. The I2 binding domain on B-CK was predicted by molecular modelling using the SiteFinder option within MOE. Outside the active site, the top ranking binding site of chicken B-CK was a pocket adjacent to the active site encompassing amino acid residues Thr71, Val72, Val75, Leu201, Leu202, Cys283 and Ser285 amongst others.
###end p 20
###begin p 21
###xml 218 224 218 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
GOLD was utilised to predict a docking mode for both 2-BFI and BU99006, in their protonated form, in the site encompassing Cys283 defined by MOE. Both structures docked readily to this site (illustrated for BU99006 in Fig. 5). The proximity of the 2-BFI and BU99006 structures to Cys283 suggests that this nucleophilic residue could be responsible for the covalent interaction with BU99006. Covalent attachment of BU99006 to Cys283, followed by minimization, led to partial occupation of the enzyme active site (data not shown), which could explain the results from the pharmacological studies where this compound inhibited B-CK activity.
###end p 21
###begin title 22
Discussion
###end title 22
###begin p 23
###xml 263 264 251 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 373 374 361 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 431 432 419 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 529 530 517 518 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 770 771 758 759 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 315 321 <span type="species:ncbi:9986">rabbit</span>
###xml 326 329 <span type="species:ncbi:10116">rat</span>
The present study reports the identification of a approximately 45 kDa imidazoline binding protein as brain creatine kinase (B-CK, 43 kDa, EC 2.7.3.2); this success was made possible largely due to the use of an affinity column generated with a highly selective I2 ligand, 2-BFI. This finding was confirmed in both rabbit and rat, the species most intensively studied for I2 binding sites. We demonstrated that B-CK showed a high I2 binding capacity and this specific binding was abolished by pre-treatment with an irreversible I2 selective ligand, BU99006. The activity of B-CK was inhibited by BU99006 and the molecular modelling predicted, with high probability, a binding pocket adjacent to the active site of B-CK. Our data clearly demonstrate the existence of an I2 binding site on B-CK.
###end p 23
###begin p 24
###xml 823 849 811 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib44" ref-type="bibr">Wallimann and Hemmer, 1994</xref>
###xml 937 963 925 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib26" ref-type="bibr">Lerner and Friedhoff, 1980</xref>
###xml 1019 1020 1007 1008 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1022 1023 1010 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1032 1049 1020 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr">Blum et al., 1991</xref>
###xml 1131 1150 1119 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr">Dunant et al., 1988</xref>
###xml 1520 1521 1508 1509 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1568 1569 1556 1557 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1607 1629 1595 1617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr">Heemskerk et al., 1998</xref>
###xml 1641 1642 1629 1630 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1678 1695 1666 1683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib34" ref-type="bibr">Nutt et al., 1995</xref>
###xml 1771 1772 1759 1760 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Creatine kinase (CK) is a well characterised enzyme that is particularly important for energy homeostasis in cells. Briefly, CK transfers a phosphoryl group between ADP and ATP using creatine as an intermediate; the peptide sequence of CK across all species is highly conserved with approximately 60% homology. There are two cytosolic isoenzymes, brain (B-) and muscle (M-) CK that are active in mono- or heterodimers and there are a further two mitochondrial octameric isoenzymes. Cytosolic B-CK converts ADP to ATP using phosphocreatine at sites of high energy demand and also converts ATP to phosphocreatine for energy storage, whereas mitochondrial creatine kinase preferentially uses ATP synthesised from oxidative phosphorylation to convert creatine to phosphocreatine and exports this to cytoplasm (for a review see Wallimann and Hemmer, 1994). B-CK is a cytosolic enzyme, but it is often tightly associated to synaptic vesicles (Lerner and Friedhoff, 1980) or directly and tightly coupled with membrane bound Na+/K+-ATPase (Blum et al., 1991) and also, CK has previously been reported to modulate neurotransmitter release (Dunant et al., 1988). Therefore, it is possible that a population of B-CK, which is bound to synaptic vesicles or to plasma membranes in neurons, is involved in neurotransmitter release as well as in the maintenance of membrane potential through the Na+/K+ ATPase. Such a population of membrane associated B-CK may explain how B-CK, typically a cytosolic soluble protein, remained in our P2 membrane preparation. There is evidence that I2 sites are found in plasma membranes (Heemskerk et al., 1998) and that I2 ligands elevate monoamine release (Nutt et al., 1995). To this end, further studies are required to investigate whether or not I2 ligands modulate neurotransmitter release through B-CK.
###end p 24
###begin p 25
###xml 176 177 176 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 201 219 201 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib28" ref-type="bibr">Lione et al., 1996</xref>
###xml 270 271 270 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 420 421 420 421 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 479 480 479 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 187 193 <span type="species:ncbi:9986">rabbit</span>
It was clear from the present study that B-CK contained a binding site for 2-BFI and the concentration of 2-BFI used has previously been shown to saturate a high component of I2 sites in rabbit brain (Lione et al., 1996). Under these assay conditions one could propose [3H]-2-BFI specifically bound to B-CK with apparent high affinity. This specific binding was abolished when B-CK was pre-treated with an irreversible I2 ligand, BU99006, further indicating the existence of an I2 binding domain in this enzyme.
###end p 25
###begin p 26
###xml 515 516 515 516 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 548 549 548 549 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1159 1178 1159 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr">Furter et al., 1993</xref>
The results from the molecular modelling studies suggest that 2-BFI binds to B-CK in a cleft or a binding pocket adjacent to the active site. Access to this pocket does not appear to be a requirement for the catalytic activity of the enzyme suggesting that 2-BFI may occupy this site without interfering or affecting the activity of B-CK. This could explain the results of the radioligand binding assay and enzyme activity assay, in which only the irreversible ligand (BU99006) inhibited B-CK activity; reversible I2 ligands with high affinity at I2 sites tested in this study had no effect on B-CK activity. While docking studies indicate that BU99006 is able to reversibly occupy this cleft, results from pharmacological assays demonstrate that it irreversibly binds to and inhibits B-CK. The most suitable nucleophile located near the preferred binding pocket is Cys283. This residue is highly reactive and is conserved in all known peptide sequences of CK. The importance of Cys283 in enzyme activity was heavily debated until site-directed mutagenesis studies showed it plays a role in substrate binding synergism but not directly involved in catalysis (Furter et al., 1993). It is possible that BU99006 acts as an effective enzyme inhibitor by covalently binding to this residue and thus disturbing the synergism. In addition, the modelling studies indicate that the preferred binding mode for BU99006 upon covalent attachment results in partial occupation of the enzyme active site, which could be another explanation for the inhibitory effect.
###end p 26
###begin p 27
###xml 59 60 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 73 74 73 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 323 324 323 324 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 602 603 602 603 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 798 799 797 798 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 911 912 910 911 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1158 1159 1156 1157 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The contradiction between the high affinity of reversible I2 ligands at I2 sites and lack of effects on the B-CK activity draws attention. We propose below the possible and likely explanations for the discrepancies observed in this study. Firstly, as described above, our molecular modelling predicted the existence of an I2 site within B-CK adjacent to the active site, and that the covalent attachment of BU99006 at the reactive Cys283 leads to a partial occupation of the active site. It is possible that, without the covalent attachment and the resulting partial occupation of the active site, an I2 ligand does not act as an effective enzyme inhibitor at the concentration tested (20 muM). Secondly, the discrepancies may have arisen because the concentration of the reversible (competitive) I2 ligands used in the assay was too low relative to the concentration of the substrate; and thus the reversible I2 ligands were unable to compete with the high concentration of the substrate (muM against mM). Nevertheless, B-CK clearly presents a functional target for BU99006 and further studies are required to confirm its functional interaction with other I2 ligands.
###end p 27
###begin p 28
###xml 99 100 99 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 168 169 168 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 228 229 228 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 277 320 277 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib29 bib41" ref-type="bibr">Lione et al., 1998; Sistermans et al., 1995</xref>
Taken together, our data demonstrate that B-CK is an imidazoline binding protein that contains an I2 binding site. However, there are likely to be other proteins with I2 binding sites in brain since the distribution pattern of I2 sites does not completely mirror that of B-CK (Lione et al., 1998; Sistermans et al., 1995).
###end p 28
###begin p 29
###xml 189 190 177 178 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 321 339 309 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr">David et al., 1998</xref>
###xml 478 505 454 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr">Garc&#237;a-Sevilla et al., 1998</xref>
###xml 618 619 594 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 684 705 660 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib38" ref-type="bibr">Reynolds et al., 1996</xref>
###xml 791 809 767 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr">Gines et al., 2003</xref>
###xml 923 944 899 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib30" ref-type="bibr">Matthews et al., 1998</xref>
###xml 1238 1259 1214 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4" ref-type="bibr">Burbaeva et al., 2003</xref>
###xml 1298 1299 1274 1275 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1409 1410 1385 1386 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1445 1446 1421 1422 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
How does the expression profile of approximately 45 kDa imidazoline binding protein compare with that of B-CK? In some neurodegenerative disorders changes in expression levels of B-CK and I2 binding proteins are independently observed. For example, in Alzheimer's disease, a membrane associated CK fraction is increased (David et al., 1998), which is consistent with the increased imidazoline binding protein of approximately 45 kDa detected by immunoblotting in this disorder (Garcia-Sevilla et al., 1998). Other changes have been observed in animal models of Huntington's disease; we have previously shown that the I2 binding site is greatly reduced in Huntington's disease brains (Reynolds et al., 1996). Animal models suggest that the ATP synthesis is impaired in Huntington's diseases (Gines et al., 2003) and the administration of creatine increases the brain phosphocreatine level eliciting neuroprotective effects (Matthews et al., 1998). If this impairment of energy metabolism was due to a depletion of cellular energy stores, namely phosphocreatine, then it could be speculated that B-CK expression is altered in this disorder. In addition, it has been reported that the B-CK level is decreased in the brain of schizophrenics (Burbaeva et al., 2003). To date, the relationships between I2 sites and schizophrenia remain unknown; however, investigations into possible modulations in the density of I2 sites and/or possible effects of I2 ligands in this disorder would make interesting studies.
###end p 29
###begin p 30
###xml 35 36 35 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 218 237 218 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr">Dunant et al., 1988</xref>
###xml 283 284 283 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 399 435 399 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13 bib35" ref-type="bibr">Finn et al., 2003; Nutt et al., 1997</xref>
###xml 597 600 597 600 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATP</sub>
###xml 612 633 612 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6" ref-type="bibr">Crawford et al., 2002</xref>
###xml 679 682 679 682 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATP</sub>
###xml 718 745 715 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib24" ref-type="bibr">Krippeit-Drews et al., 2003</xref>
###xml 827 828 824 825 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 834 835 831 832 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 854 857 851 854 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATP</sub>
###xml 922 941 916 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib33" ref-type="bibr">Morgan et al., 1999</xref>
###xml 1009 1033 1003 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22" ref-type="bibr">Ikeda and Tomonaga, 1988</xref>
###xml 1046 1047 1040 1041 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1073 1091 1067 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib29" ref-type="bibr">Lione et al., 1998</xref>
###xml 1123 1126 1117 1120 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATP</sub>
###xml 1348 1351 1342 1345 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATP</sub>
###xml 1461 1478 1455 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib31" ref-type="bibr">Miki et al., 2001</xref>
###xml 1531 1534 1525 1528 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATP</sub>
###xml 1731 1732 1725 1726 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1775 1776 1769 1770 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1786 1805 1780 1799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib21" ref-type="bibr">Hudson et al., 2001</xref>
###xml 1984 1985 1978 1979 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 393 397 <span type="species:ncbi:10116">rats</span>
To what extent can the actions of I2 ligands be explained through an interaction with B-CK? B-CK is prominently expressed in neurons and it has been shown to influence membrane potentials and neurotransmitter release (Dunant et al., 1988). This could explain the mechanism by which I2 ligands may affect dopamine, 5-HT and noradrenaline release as well as their antidepressant-like actions in rats (Finn et al., 2003; Nutt et al., 1997). It has been reported that CK is directly and physically associated with the SUR2A subunit, but not the Kir6.2 subunit of the cardiac ATP sensitive potassium (KATP) channels (Crawford et al., 2002). Also, there is evidence that CK regulates KATP channels in pancreatic beta-cells (Krippeit-Drews et al., 2003) where B-CK is the major CK isoenzyme present. Interestingly, we know that some I2 and I3 ligands regulate KATP channels in pancreatic beta-cells leading to insulin secretion (Morgan et al., 1999). CK is present in the hypothalamus including the arcuate nucleus (Ikeda and Tomonaga, 1988) where the I2 site is highly abundant (Lione et al., 1998), and a link between B-CK and KATP channels has been suggested to be important in the regulation of hypothalamic glucose-responsive (GR) neuronal activity. Hypothalamic GR neurons increase their firing rate with increased extracellular glucose levels and KATP channels in the hypothalamic GR neurons have been strongly suggested to be involved in the appetite control (Miki et al., 2001). Preliminary studies have shown that 2-BFI blocks KATP channels on hypothalamic GR neurons (personal communication with Professor M. Ashford, University of Dundee, U.K.). This may provide an explanation for the acute stimulation of eating induced by I2 ligands and the potassium sensitivity of I2 binding (Hudson et al., 2001). Undeniably, these hypotheses need to be examined thoroughly in future studies. In addition, further investigations should determine whether or not the changes in the level of I2 binding sites found in conditions such as schizophrenia, Huntington's disease, depression and opiate dependence are accompanied by similar alterations in B-CK expression, as seems to be the case in Alzheimer's disease.
###end p 30
###begin p 31
###xml 150 151 138 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 262 263 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In conclusion, we report the identity of a approximately 45 kDa imidazoline binding protein to be brain creatine kinase and this enzyme possesses an I2 binding site. These striking findings will undoubtedly contribute to greater understanding of the effects of I2 ligands in psychiatric disorders and to developing such ligands as novel therapeutic drugs.
###end p 31
###begin title 32
Experimental procedures
###end title 32
###begin title 33
Materials
###end title 33
###begin p 34
###xml 563 564 536 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 605 608 578 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#160;1</sup>
###xml 73 79 <span type="species:ncbi:9986">Rabbit</span>
PharmaLinktrade mark was purchased from Perbio Science, Cramlington, UK. Rabbit B-CK and protease inhibitors cocktail were purchased from Sigma, Poole, UK. Microceptrade mark and Nanocepstrade mark were purchased from Pall Life Sciences, Portsmouth, UK. Coomassie Brilliant Blue R-250 was obtained from Bio-Rad Laboratories, Hemel Hempstead, UK. 2-(2-benzofuranyl)2-imidazoline (2-BFI), 2-(4,5-dihydroimidaz-2-yl)quinoline (BU224) and 5-isothiocyanato-2-benzofuranyl-2-imidazoline (BU99006) were kindly synthesised by Dr S. M. Husbands, University of Bath, U.K. [3H]-2-BFI (specific activity of 70 Ci mmol- 1) was purchased from GE Healthcare, Amersham, U.K.
###end p 34
###begin title 35
###xml 35 36 23 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Isolation of approximately 45 kDa I2 binding protein using a 2-BFI affinity column
###end title 35
###begin p 36
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.v.</italic>
###xml 234 235 234 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 285 303 285 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib28" ref-type="bibr">Lione et al., 1996</xref>
###xml 313 314 313 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 493 494 493 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 973 1012 943 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11 bib45" ref-type="bibr">Escrib&#225; et al., 1995; Wang et al., 1992</xref>
###xml 1154 1157 1112 1115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#160;1</sup>
###xml 1230 1231 1176 1177 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1604 1607 1550 1553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#160;1</sup>
###xml 1778 1779 1715 1716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 18 25 <span type="species:ncbi:9986">rabbits</span>
###xml 137 141 <span type="species:ncbi:10116">rats</span>
New Zealand White rabbits of either sex (2.5-4 kg) were killed by a schedule 1 method (overdose of pentobarbitone, i.v.) and Wistar male rats (200-250 g) were killed by cervical dislocation. Whole brains were immediately removed and P2 membranes were prepared as described previously (Lione et al., 1996). These P2 membranes were solubilised in 0.5% CHAPS in the presence of protease inhibitors cocktail. The mixture was constantly stirred for 2 h on ice followed by centrifugation at 100,000 g for 30 min at 4 degreesC. A 2-BFI affinity column was synthesised using PharmaLinktrade mark. The PharmaLinktrade mark gel (10 ml) was incubated with 20 mM 2-BFI in 0.1 M MES, pH 4.7, in the presence of formaldehyde (2.5%v/v final) for 40 h at 40 degreesC with constant agitation. The gel was then transferred into a column (2.5 x 10 cm) and unbound 2-BFI was washed off with 0.1 M Tris, pH 8.0 (240 ml). Affinity chromatography was performed similarly to previously described (Escriba et al., 1995; Wang et al., 1992). The 2-BFI affinity column was equilibrated with 0.05% CHAPS (50 ml) prior to the loading of the solubilised proteins (approximately 2 mg ml- 1, approximately 17 ml). The column was then washed with 0.05% CHAPS and I2 binding proteins bound to the 2-BFI affinity column were eluted off with 20 mM idazoxan. The column was again washed with 0.05% CHAPS before all the residual proteins were removed by 1 M NaCl. The amount of proteins eluted was monitored by measuring their absorbance at 280 nm using a UV monitor (Model EM-1 Econo UV monitor, Bio-Rad Laboratories). The flow rate (1 ml min- 1) was maintained by a peristaltic pump. The fractions eluted with 20 mM idazoxan (6 ml) were collected and concentrated using Microceptrade mark by centrifugation at 5700 g for 90 min.
###end p 36
###begin title 37
###xml 33 34 33 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
SDS-PAGE and electroblotting of I2 binding proteins onto PVDF membranes
###end title 37
###begin p 38
###xml 58 72 58 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib25" ref-type="bibr">Laemmli (1970)</xref>
###xml 222 245 222 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9" ref-type="bibr">Dunbar and Wilson, 1994</xref>
###xml 746 749 739 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
SDS-PAGE (12%) was carried out according to the method of Laemmli (1970) and the gel was stained with Coomassie Blue. For protein blotting for the sequencer, previously described method was used with slight modifications (Dunbar and Wilson, 1994). Briefly, piperazine diacrylamide was used as a cross-linker and the gel was pre-run with 50 muM reduced glutathione for 1 h at 5 mA. The concentrated sample was mixed with a loading buffer (62.5 mM Tris-HCl (pH 6.8), 3% w/v SDS, 5% v/v mercaptoethanol, 25% v/v glycerol, and 0.05% w/v bromophenol blue) and heated for 10 min at 100 degreesC to denature the proteins. The final samples were loaded onto pre-run gel, which ran at 18 mA. Proteins were blotted onto PVDF membranes using Mini Trans-Blot(R) Cell (Bio-Rad Laboratories) for 2 h at 300 mA.
###end p 38
###begin title 39
###xml 43 44 43 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
N-terminal protein sequencing of isolated I2 binding protein
###end title 39
###begin p 40
The approximately 45 kDa band on PVDF membranes was excised then sequenced using Applied Biosystems Procise sequencer (Applied Biosystems, Warrington, U.K.), which utilises the classic Edman degradation procedure.
###end p 40
###begin title 41
Radioligand binding assay
###end title 41
###begin p 42
###xml 43 44 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 80 81 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 103 106 102 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#160;1</sup>
###xml 406 407 398 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 702 703 688 689 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 888 889 867 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 958 959 928 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 0 6 <span type="species:ncbi:9986">Rabbit</span>
###xml 23 29 <span type="species:ncbi:9986">rabbit</span>
Rabbit B-CK (5 mug) or rabbit whole brain P2 membranes was incubated with 5 nM [3H]-2-BFI and 0.8 mg ml- 1 BSA for 30 min at 20 degreesC in the presence or absence of BU224 (10 muM) to establish specific binding. The reaction was terminated by the addition of polyethylene glycol (12.5% final). The samples were mixed well and precipitated proteins were separated from solution by centrifugation at 11,000 g for 10 min at 4 degreesC. The supernatant was discarded and the remaining pellets were briefly rinsed twice in ice-cold Tris-HCl buffer (50 mM Tris, 1 mM MgCl; pH 7.4). Scintillation fluid (12 ml) was added and the radioactivity remained in the samples was counted. For pre-treatment with the I2 irreversible ligand, the samples were incubated with BU99006 (10 muM) for 20 min at 37 degreesC followed by two washes in ice-cold Tris-HCl buffer by repeated centrifugation at 11,000 g for 5 min using Nanocepstrade mark before they were incubated with [3H]-2-BFI and subjected to the above procedures.
###end p 42
###begin title 43
B-CK activity assay
###end title 43
###begin p 44
###xml 70 107 70 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14 bib40" ref-type="bibr">Florini, 1989; Shainberg et al., 1971</xref>
###xml 465 466 465 466 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 423 429 <span type="species:ncbi:9986">Rabbit</span>
The protocol used was modified from the methods described previously (Florini, 1989; Shainberg et al., 1971). The final composition of the assay mixture was 20 mM glucose, 10 mM magnesium acetate, 1 mM ADP, 10 mM AMP, 0.4 mM thio-NAD, 10 mM dithiothreitol, 0.5 U/ml hexokinase, 1 U/ml glucose-6-phosphate dehydrogenase and a range of phosphocreatine concentrations between 0 and 35 mM, all in 0.1 M glycylglycine, pH 6.75. Rabbit B-CK was pre-treated with various I2 ligands (1-20 muM) for 20 min at 37 degreesC before it was added to the assay mixture. The absorbance at 405 nm was measured for obtaining the initial velocities at 25 degreesC over 50 min using a 96 well plate reader. The results were analysed and graphs were created using GraphPad Prism 3.0.
###end p 44
###begin title 45
###xml 48 49 48 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Molecular modelling of the interaction between I2 ligands and B-CK crystal structure
###end title 45
###begin p 46
###xml 37 44 <span type="species:ncbi:9031">chicken</span>
The crystal structure (PDB: 1QH4) of chicken brain B-CK was utilised for the modelling studies. Hydrogens were added and minimised using the MMFF94 force field implemented within MOE (Chemical Computing Group, 2003.02) and keeping all other atoms fixed. 2-BFI and BU99006 were drawn using the Build option of MOE, keeping the imidazoline ring protonated and minimised using the MMFF94 force field.
###end p 46
###begin p 47
2-BFI and BU99006 were docked to 1QH4 using GOLD (CCDC Software Ltd) with the GOLD Score Fitness Function. In addition, based on the reversibly docked structure with BU99006, we simulated covalent bond formation between Cys283 and the isothiocyanate group of BU99006 and the resulting modified protein was minimised using the MMFF94 forcefield. In this latter minimization step, only BU99006 and residues having an atom within 3 Angstroms of Cys283 were left flexible, all others were fixed.
###end p 47
###begin title 48
Acknowledgments
###end title 48
###begin p 49
Authors would like to thank Dr Graham Kemp at the University of St Andrews for the protein sequencing. This study was funded by Yamanouchi UK Ltd and the Wellcome Trust (grant number 06956).
###end p 49
###begin title 50
References
###end title 50
###begin article-title 51
###xml 90 93 <span type="species:ncbi:10116">rat</span>
Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes
###end article-title 51
###begin article-title 52
###xml 156 176 <span type="species:ncbi:307038">Narcine brasiliensis</span>
Coupled in vivo activity of creatine phosphokinase and the membrane-bound (Na+,K+)-ATPase in the resting and stimulated electric organ of the electric fish Narcine brasiliensis
###end article-title 52
###begin article-title 53
Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines
###end article-title 53
###begin article-title 54
Creatine kinase BB in brain in schizophrenia
###end article-title 54
###begin article-title 55
The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites
###end article-title 55
###begin article-title 56
Creatine kinase is physically associated with the cardiac ATP-sensitive K+ channel in vivo
###end article-title 56
###begin article-title 57
Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning
###end article-title 57
###begin article-title 58
Energy metabolism and quantal acetylcholine release: effects of botulinum toxin, 1-fluoro-2,4-dinitrobenzene, and diamide in the Torpedo electric organ
###end article-title 58
###begin article-title 59
A buffer exchange procedure giving enhanced resolution to polyacrylamide gels prerun for protein sequencing
###end article-title 59
###begin article-title 60
'Seeing through a glass darkly': casting light on imidazoline 'I' sites
###end article-title 60
###begin article-title 61
###xml 98 101 <span type="species:ncbi:10116">rat</span>
Molecular characterization and isolation of a 45-kilodalton imidazoline receptor protein from the rat brain
###end article-title 61
###begin article-title 62
Pharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods
###end article-title 62
###begin article-title 63
###xml 118 122 <span type="species:ncbi:10116">rats</span>
###xml 127 131 <span type="species:ncbi:10116">rats</span>
Behavioral, neuroendocrine and neurochemical effects of the imidazoline I(2) receptor selective ligand BU224 in naive rats and rats exposed to the stress of the forced swim test
###end article-title 63
###begin article-title 64
Assay of creatine kinase in microtiter plates using thio-NAD to allow monitoring at 405 nM
###end article-title 64
###begin article-title 65
Creatine kinase: the reactive cysteine is required for synergism but is nonessential for catalysis
###end article-title 65
###begin article-title 66
###xml 82 90 <span type="species:ncbi:9606">patients</span>
Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims
###end article-title 66
###begin article-title 67
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Imidazoline receptor proteins in brains of patients with Alzheimer's disease
###end article-title 67
###begin article-title 68
###xml 110 114 <span type="species:ncbi:10090">mice</span>
Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice
###end article-title 68
###begin article-title 69
###xml 105 111 <span type="species:ncbi:9913">bovine</span>
Evidence for the existence of imidazoline-specific binding sites in synaptosomal plasma membranes of the bovine brainstem
###end article-title 69
###begin article-title 70
###xml 75 78 <span type="species:ncbi:10116">rat</span>
72 hour morphine treatment decreases the density of Imidazoline-2 sites in rat brain
###end article-title 70
###begin article-title 71
Imidazoline receptors and their role in depression
###end article-title 71
###begin article-title 72
###xml 122 127 <span type="species:ncbi:10090">mouse</span>
Creatine kinase immunoreactivity: localization in nerve terminals in the hypothalamic area and superior colliculus of the mouse brain
###end article-title 72
###begin article-title 73
Interactions of imidazoline ligands with the active site of purified monoamine oxidase A
###end article-title 73
###begin article-title 74
Phosphocreatine as a determinant of K<inf>ATP</inf> channel activity in pancreatic beta-cells
###end article-title 74
###begin article-title 75
###xml 67 83 <span type="species:ncbi:10665">bacteriophage T4</span>
Cleavage of structural proteins during the assembly of the head of bacteriophage T4
###end article-title 75
###begin article-title 76
Characterization of a brain particulate bound form of creatine kinase
###end article-title 76
###begin article-title 77
Agmatine: an endogenous clonidine-displacing substance in the brain
###end article-title 77
###begin article-title 78
###xml 97 103 <span type="species:ncbi:9986">rabbit</span>
[3H]2-(2-benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors
###end article-title 78
###begin article-title 79
###xml 85 88 <span type="species:ncbi:10116">rat</span>
Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptors
###end article-title 79
###begin article-title 80
Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease
###end article-title 80
###begin article-title 81
ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis
###end article-title 81
###begin article-title 82
S1P-receptors in PC12 and transfected HEK293 cells: molecular targets of hypotensive imidazoline I(1) receptor ligands
###end article-title 82
###begin article-title 83
Imidazolines and pancreatic hormone secretion
###end article-title 83
###begin article-title 84
Functional studies of specific imidazoline-2 receptor ligands
###end article-title 84
###begin article-title 85
Noradrenergic mechanisms in the prefrontal cortex
###end article-title 85
###begin article-title 86
###xml 160 163 <span type="species:ncbi:10116">rat</span>
Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver
###end article-title 86
###begin article-title 87
The elusive family of imidazoline binding sites
###end article-title 87
###begin article-title 88
Imidazoline binding sites in Huntington's and Parkinson's disease putamen
###end article-title 88
###begin article-title 89
Decreased density of I2-imidazoline receptors in the postmortem brain of heroin addicts
###end article-title 89
###begin article-title 90
Alterations of enzymatic activities during muscle differentiation in vitro
###end article-title 90
###begin article-title 91
Tissue- and cell-specific distribution of creatine kinase B: a new and highly specific monoclonal antibody for use in immunohistochemistry
###end article-title 91
###begin article-title 92
Modulation of stress by imidazoline binding sites: implications for psychiatric disorders
###end article-title 92
###begin article-title 93
###xml 149 152 <span type="species:ncbi:10116">rat</span>
5-Isothiocyanato-2-benzofuranyl-2-imidazoline (BU99006) an irreversible imidazoline(2) binding site ligand: in vitro and in vivo characterisation in rat brain
###end article-title 93
###begin article-title 94
Creatine kinase in non-muscle tissues and cells
###end article-title 94
###begin article-title 95
###xml 68 74 <span type="species:ncbi:9913">bovine</span>
Isolation and characterization of imidazoline receptor protein from bovine adrenal chromaffin cells
###end article-title 95
###begin article-title 96
The Protein Information Resource: an integrated public resource of functional annotation of proteins
###end article-title 96
###begin p 97
###xml 34 35 34 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Chemical structures of selective I2 ligands.
###end p 97
###begin p 98
###xml 5 6 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 760 761 760 761 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 29 35 <span type="species:ncbi:9986">rabbit</span>
###xml 782 788 <span type="species:ncbi:9986">rabbit</span>
(A) I2 binding proteins from rabbit brain isolated using a 2-BFI affinity column (lane B), molecular markers (lanes A and C) and proteins eluted from the control (blank) column (D), in which 2-BFI link was absent. Proteins were separated by SDS-PAGE (12%) and gels were stained with Coomassie Blue. As expected, a strong band at  ~45 kDa and a few other weaker bands were detected. This  ~45 kDa protein was absent from proteins eluted from the control column indicating that it specifically bound to the 2-BFI affinity column. The proteins eluted from the 2-BFI affinity column were transferred onto PVDF membranes and the  ~45 kDa band was subjected to protein sequencing. (B) Complete match of N-terminal protein sequences (10 amino acids) of the  ~45 kDa I2 binding protein and rabbit brain creatine kinase (EC 2.7.3.2). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
###end p 98
###begin p 99
###xml 21 22 21 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 240 243 237 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#160;1</sup>
###xml 245 246 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 294 297 289 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#160;1</sup>
###xml 299 300 294 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 364 365 359 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 373 374 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 388 389 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 411 412 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 454 455 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 34 40 <span type="species:ncbi:9986">rabbit</span>
###xml 74 80 <span type="species:ncbi:9986">rabbit</span>
###xml 104 110 <span type="species:ncbi:9986">rabbit</span>
Specific binding of [3H]-2-BFI to rabbit brain creatine kinase (B-CK) and rabbit whole brain membranes (rabbit WB; control) with or without BU99006 (10 muM) pre-treatment. The specific binding to the control (568.8 +/- 116.5 fmol mg protein- 1, n = 9) and B-CK (2329.5 +/- 814.8 fmol mg protein- 1, n = 7) was abolished after pre-treatment with BU99006 (Student's t-test, *P < 0.04 and **P < 0.03 respectively, n = 4). These data represent mean +/- SEM, n = 4-9.
###end p 99
###begin p 100
###xml 182 185 181 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 195 196 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Dose-dependent inhibition of B-CK activity by BU99006 (5, 10 and 20 muM; pre-incubation), using phosphocreatine (0-35 mM) as the substrate. The data show mean percentage control to Vmax +/- SEM, n = 4.
###end p 100
###begin p 101
###xml 64 71 <span type="species:ncbi:9031">chicken</span>
BU99006 docking to a crystal structure of the catalytic site of chicken brain creatine kinase (PDB: 1QH4). Amino acid residues in proximity to BU99006 (centre) were labelled including Cys283 (bottom centre). The isothiocyanate group on BU99006 is projected away from Cys283 in this illustration but the dynamic situations in vivo would allow the BU99006 to flip, making it within the reach of Cys283 forming a covalent bond. Also, it is possible that the covalent bonds are formed during the entry or exit of BU99006 to the binding pocket. 2-BFI, which shares the same structure as BU99006 apart from the isothiocyanate group, reversibly binds to this same pocket.
###end p 101

